Prostatic Hyperplasia Clinical Trials

6 recruiting

Prostatic Hyperplasia Trials at a Glance

68 actively recruiting trials for prostatic hyperplasia are listed on ClinicalTrialsFinder across 6 cities in 36 countries. The largest study group is Not Applicable with 40 trials, with the heaviest enrollment activity in Cleveland, Las Vegas, and Beijing. Lead sponsors running prostatic hyperplasia studies include Beth Israel Deaconess Medical Center, Centre hospitalier de l'Université de Montréal (CHUM), and National Cancer Institute (NCI).

Browse prostatic hyperplasia trials by phase

Treatments under study

About Prostatic Hyperplasia Clinical Trials

Looking for clinical trials for Prostatic Hyperplasia? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Prostatic Hyperplasia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Prostatic Hyperplasia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 68 trials

Recruiting

Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer

Prostate CancerProstatic CancerProstatic Hyperplasia+1 more
National Cancer Institute (NCI)10,000 enrolled1 locationNCT03354416
Recruiting
Not Applicable

EEAP Using Moses 2.0 Technology vs the Thulium Fiber Laser in Medium-Large Prostates

SurgeryProstatic HyperplasiaEndoscopic Anatomical Enucleation of the Prostate (EEAP)
Fundacio Puigvert120 enrolled3 locationsNCT06565741
Recruiting

BPH Global Registry

Benign Prostatic HyperplasiaLower Urinary Tract Symptoms
Société Internationale d'Urologie7,500 enrolled26 locationsNCT05543200
Recruiting
Phase 2

Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer

Prostatic HyperplasiaUrinary Urge IncontinenceStress Urinary Incontinence
National Cancer Institute (NCI)41 enrolled1 locationNCT06161506
Recruiting
Not Applicable

Ambulatory Long Length URodynamics Evaluation

Benign Prostatic HyperplasiaUrodynamicsUrinary Bladder, Overactive+4 more
Bright Uro101 enrolled7 locationsNCT07425015
Recruiting
Not Applicable

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Prostate CancerProstatectomyBenign Prostatic Hyperplasia+3 more
Axonics, Inc.150 enrolled20 locationsNCT06511141
Recruiting
Not Applicable

Comparison of Functional Outcomes of Ejaculation-preserving Partial Trans Urethral Resection of the Prostate With Complete Trans Urethral Resection of the Prostate for Benign Prostatic Obstruction

Benign Prostatic Hyperplasia
University Hospital, Bordeaux336 enrolled17 locationsNCT05574244
Recruiting
Not Applicable

The Edison System for Treatment of Benign Prostatic Hyperplasia (BPH) Using Histotripsy

Benign Prostatic Hyperplasia
HistoSonics, Inc.80 enrolled1 locationNCT07214675
Recruiting

Impact of Long-term Dutasteride Use on Perioperative Outcomes of HoLEP

Prostatic Hyperplasia, Benign
Ankara City Hospital Bilkent1,000 enrolled1 locationNCT07417449
Recruiting

OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH

Benign Prostatic Hyperplasia
Urotronic Inc.500 enrolled9 locationsNCT06560476
Recruiting
Phase 2

New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia

Lower Urinary Track SymptomsBPH (Benign Prostatic Hyperplasia)
Beth Israel Deaconess Medical Center242 enrolled1 locationNCT06944145
Recruiting
Not Applicable

A Prospective, Multicenter, Open-label Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)

Benign Prostatic Hyperplasia
Andromeda Surgical54 enrolled3 locationsNCT06668142
Recruiting
Not Applicable

Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)

Benign Prostatic HyperplasiaAnticoagulant Adverse Reaction
Clinique Pasteur389 enrolled1 locationNCT03297281
Recruiting
Phase 1

A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects

Benign Prostatic Hyperplasia
Addpharma Inc.44 enrolled1 locationNCT07444385
Recruiting
Not Applicable

Comparison Between Water Vapor Thermal Therapy and Prostatic Artery Embolization in Treatment of Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms
Ain Shams University30 enrolled1 locationNCT07416227
Recruiting
Not Applicable

Local Anesthesia With Schelin Catheter in Rezum Treatment: a Randomized Controlled Trial

Benign Prostatic Hyperplasia
Assistance Publique Hopitaux De Marseille24 enrolled1 locationNCT06657872
Recruiting
Phase 2

Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization

Prostate CarcinomaBenign Prostatic Hyperplasia
H. Lee Moffitt Cancer Center and Research Institute26 enrolled1 locationNCT04879940
Recruiting

Laser Ablation a Salvage Treatment for Obstructive Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia (BPH)
The Cleveland Clinic20 enrolled1 locationNCT07016620
Recruiting
Not Applicable

INTUPRO in the Treatment of Benign Prostatic Hyperplasia-Related Symptoms

BPH (Benign Prostatic Hyperplasia)BPHBPH With Other Lower Urinary Tract Symptoms
inTumo Therapeutics, Inc.31 enrolled1 locationNCT07381127
Recruiting
Phase 4

A Clinical Observation Study of a Chinese Patent Medicine Combined With Tamsulosin in Improving Sleep and Nocturia Symptoms After Enucleation of the Prostate

Benign Prostatic HyperplasiaNocturia Associated With Nocturnal Polyuria
The Fourth Affiliated Hospital of Zhejiang University School of Medicine136 enrolled1 locationNCT07357324